Related Experiment Video
Updated: Jun 1, 2026
06:03
Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
[Pulmonary fibrosis and emphysema].
1Centre valaisan de pneumologie, CHCVS, 3963 Crans-Montana.
Revue Medicale Suisse
|May 21, 2011
Summary
Combined pulmonary fibrosis and emphysema (CPFE) is a syndrome affecting smokers, characterized by upper-lobe emphysema and lower-lung fibrosis. Diagnosis relies on CT scans, and pulmonary hypertension is a key negative prognostic factor.
Area of Science:
- Pulmonology
- Radiology
- Pathology
Context:
- Combined pulmonary fibrosis and emphysema (CPFE) is a distinct interstitial lung disease.
- This syndrome predominantly affects male smokers and ex-smokers, typically around 65 years of age.
- Key clinical features include exertional dyspnea, reduced pulmonary function, and exercise-induced hypoxemia.
Purpose:
- To describe the clinical, radiological, and prognostic features of combined pulmonary fibrosis and emphysema.
- To highlight the diagnostic utility of high-resolution CT scans in identifying CPFE.
- To underscore the significance of pulmonary hypertension as a negative prognostic indicator.
Summary:
- CPFE presents with upper-lobe emphysema and lower-lung diffuse fibrosing disease, as visualized on high-resolution CT scans.
- Pulmonary function tests often show subnormal results, reduced carbon monoxide transfer, and exercise hypoxemia.
- Pulmonary hypertension is observed in nearly 50% of patients and is a major factor influencing prognosis.
Impact:
- This case report contributes to the understanding of a recently described smoking-related lung disease.
- Early diagnosis through high-resolution CT can facilitate timely management strategies.
- Identifying pulmonary hypertension is crucial for patient management and predicting survival outcomes.
Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.